Advanced search
Publication Cover
Journal of Chemotherapy Volume 7, 1995 - Issue 5
Submit an article Journal homepage
23
Views
8
CrossRef citations to date
0
Altmetric
Articles

Chemotherapy in Gastric Cancer: An Economic Evaluation of the FAM (5-Fluorouracil, Adriamycin, Mitomycin C) versus ELF (Etoposide, Leucovorin, 5-Fluorouracil) Regimenshtml

J. Norum
&
V. Angelsen
Pages 455-459 | Published online: 20 Nov 2013

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Eva Galizia, Rossana Berardi, Mario Scartozzi & Stefano Cascinu. (2004) A cost–benefit analysis of chemotherapy for gastric cancer. Expert Opinion on Pharmacotherapy 5:10, pages 2109-2114.
Read now
Göran Karlsson, Peter Nygren, Bengt Glimelius. (2001) Economic Aspects of Chemotherapy. Acta Oncologica 40:2-3, pages 412-433.
Read now

Articles from other publishers (6)

Alyson L. Mahar, Abraham El-Sedfy, Savtaj S. Brar, Ana Johnson & Natalie Coburn. (2014) Are We Lacking Economic Evaluations in Gastric Cancer Treatment?. PharmacoEconomics 33:2, pages 83-87.
Crossref
Joshua A. Roth & Josh J. Carlson. (2011) Cost-Effectiveness of Gemcitabine + Cisplatin vs. Gemcitabine Monotherapy in Advanced Biliary Tract Cancer. Journal of Gastrointestinal Cancer 43:2, pages 215-223.
Crossref
Gerald Richardson & Andrea Manca. (2004) Calculation of quality adjusted life years in the published literature: a review of methodology and transparency. Health Economics 13:12, pages 1203-1210.
Crossref
J. Brown. (1999) Economic Evaluation of Cancer Treatments: A Review of the Methods. Clinical Oncology 11:2, pages 78-83.
Crossref
T.-J. Chiou, S.-L. Tung, R.-K. Hsieh, W.-S. Wang, C.-C. Yen, F. S. Fan, J.-H. Liu & P.-M. Chen. (1998) Phase II Study of the Modified Regimen of Etoposide, Leucovorin and 5-Fluorouracil for Patients with Advanced Gastric Cancer. Japanese Journal of Clinical Oncology 28:5, pages 318-322.
Crossref
J. Norum, V. Angelsen, E. Wist & J.A. Olsen. (1996) Treatment costs in hodgkin's disease: A cost-utility analysis. European Journal of Cancer 32:9, pages 1510-1517.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.